Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trial.
尿簇蛋白作为人类肾脏疾病进展和对内皮素受体拮抗剂阿曲生坦反应的生物标志物：来自 SONAR 试验的探索性分析。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68973-5
Ju Wenjun, Nair Viji, Vart Priya, Smeijer J David, Hudkins Kelly L, Moedt Erik, Larkina Maria, Perco Paul, Burdet Frédéric, Shedden Kerby, Hwang Michael, Lee Edmond, O'Connor Christopher, Hartman John, Subramanian Lalita, Bitzer Markus, Ibberson Mark, Duffin Kevin L, Gomez Maria F, Alpers Charles E, Kretzler Matthias, Heerspink Hiddo J L
